The discovery of a novel approach to promote cardiomyocyte proliferation offers new hope for the treatment of ischemic heart failure.

A global team of researchers has reported a groundbreaking discovery in cardiac regeneration that offers new hope for the ...

The discovery of a novel approach to promote cardiomyocyte proliferation offers new hope for the treatment of ischemic heart failure. Researchers in the Michael E. DeBakey Department of Surgery at ...

Researchers report a discovery in cardiac regeneration that offers new hope for the treatment of ischemic heart failure.

A discovery in cardiac regeneration offers ew hope for the treatment of ischemic heart failure. Published in npj Regenerative ...

Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...

Researchers in the Michael E. DeBakey Department of Surgery at Baylor College of Medicine, the QIMR Berghofer Medical Research Institute in Brisbane, Australia, and collaborating institutions report a ...

A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a ...

Genentech’s label expansion for TNKase consolidates its market position for pharmacological stroke treatments.

A study has found that in patients with ischemic heart disease receiving ventricular tachycardia ablation there is higher risk of mortality.

After transcatheter patent foramen ovale (PFO) closure, patients with nickel hypersensitivity were more likely to develop ...

Researchers in the Michael E. DeBakey Department of Surgery at Baylor College of Medicine, the QIMR Berghofer Medical Research Institute in Brisbane ...